P Cool1, R Grimer, R Rees. 1. The Royal Orthopaedic Hospital, Northfield, Birmingham B31 2AP, UK. paul.cool@rjah.nhs.uk
Abstract
AIM: To evaluate the efficiency of our follow-up regime for patients with sarcoma of the extremities. METHODS: We have reviewed our follow-up policy in 480 patients with non-metastatic bone or soft tissue sarcomas and with more than 5 years of follow-up. RESULTS: We detected 24% of the soft tissue sarcoma recurrences and 38% of the bone tumour recurrences. We detected 67% of the pulmonary metastases before they became symptomatic. Only 11% of those patients who developed metastases were cured, as were only 26% of those who developed local recurrence. CONCLUSIONS: This study shows that our surveillance programme detects most metastases, but only about one third of the local recurrences.
AIM: To evaluate the efficiency of our follow-up regime for patients with sarcoma of the extremities. METHODS: We have reviewed our follow-up policy in 480 patients with non-metastatic bone or soft tissue sarcomas and with more than 5 years of follow-up. RESULTS: We detected 24% of the soft tissue sarcoma recurrences and 38% of the bone tumour recurrences. We detected 67% of the pulmonary metastases before they became symptomatic. Only 11% of those patients who developed metastases were cured, as were only 26% of those who developed local recurrence. CONCLUSIONS: This study shows that our surveillance programme detects most metastases, but only about one third of the local recurrences.
Authors: David A J Wilson; Aaron Gazendam; Julia Visgauss; David Perrin; Anthony M Griffin; Peter W Chung; Charles N Catton; David Shultz; Peter C Ferguson; Jay S Wunder Journal: Ann Surg Oncol Date: 2020-03-09 Impact factor: 5.344